Wall Street trades in narrow range as investors assess data yields


(MENAFN- ProactiveInvestors) U.S. stocks traded in a narrow range today as corporate deal activity was offset by concern a fixed-income selloff may resume and investors considered a downbeat retail sales report.

The S&P 500 (INDEXSP:.INX) inched down less than 0.1 percent to 2098 at 3:48 p.m. in New York. The 30-company Dow Jones Industrial Average (INDEXDJX:.DJI) was down 0.1 percent at 18057 while the tech-heavy Nasdaq Composite (INDEXNASDAQ:.IXIC) gained 0.1 percent to 4982. 

DATA:

In U.S. economic news the Commerce Department said Wednesday U.S. retail sales were flat in April at $436.8 billion. Economists surveyed by The Wall Street Journal had expected a 0.2 percent increase in April. Retail sales in March were revised to 1.1 percent growth from 0.9 percent previously.

MOVERS:

American Express (NYSE:AXP) rose 1.1 percent to $79.91 as the biggest U.S. credit-card issuer by customer purchases announced a 12 percent dividend increase and a new share-buyback program.

Macy's (NYSE:M) slid 2.4 percent to $63.76 after the U.S. department-store chain reported weaker-than-expected sales and profit in the first quarter. 

McKesson (NYSE:MCK) rose 1.3 percent to $232.47 as the drug distributor earned an adjusted $2.94 per share for its latest quarter beating estimates of $0.20. 

Danaher (NYSE:DHR) climbed 1.3 percent to $87.11 and Pall (NYSE:PLL) added 4.5 percent to $123.95 after Danaher agreed to buy the water-systems maker for $13.8 billion. Danaher will also split itself into two independent companies. 

Delta Airlines (NYSE:DAL) rose 1.2 percent to $46.66 after announcing a $5 billion buyback program and raised its quarterly dividend to 13.5 cents per share from $0.09.

In financials Zillow (NASDAQ:Z) fell 1.9 percent to $96.08 even as the real estate website operator reported profit of $0.05 per share better than the consensus analyst forecast of an 0.11 per share loss. Revenue was also better than expected on improved ad sales. 

HortonWorks (NASDAQ:HDP) added 0.8 percent to $21.97 after the data-software company’s second-quarter revenue forecast beat analysts’ estimates while reporting a narrower-than-expected first-quarter loss. 

Zebra Technologies (NASDAQ:ZBRA) jumped 12.5 percent to $105.38 after the Lincolnshire Illinois-based company said its first-quarter sales soared helped by a recent acquisition and saw growth in its legacy business. 

GoDaddy (NYSE:GDDY) fluctuated and was last flat at $26.75. The web-hosting company which manages nearly a fifth of the world’s internet domains reported a higher-than-expected 18 percent increase in first-quarter revenue aided by customer addition. 

Vertex Pharmaceuticals (NASDAQ:VRTX) surged 1.7 percent to $126.01 after a panel of external advisers said its experimental cystic fibrosis combination should be approved by U.S. regulators.

Orexigen Therapeutics (NASDAQ:OREX) plunged 14 percent to $5.09 as Takeda Pharmaceutical (OTCMKTS:TKPYY) threatened to end its collaboration with the drugmaker after a safety study of its obesity medicine was halted. 

In other stocks Williams Partners (NYSE:WPZ) surged 22.4 percent to $58.02 after gas infrastructure company Williams Companies (NYSE:WMB) announced an agreement to buy the public equity of Williams Partners in a stock deal valued at $13.8 billion. 

Owens-Illinois (NYSE:OI) rose 9.5 percent to $26.04 after the glass container maker said it would buy the food and beverage glass container business of Mexico's Vitro SAB de CV for $2.15 billion.

COMMODITIES:

Gold for June delivery on Comex rose 2.2 percent to settle at $1218.20 an ounce.

West Texas Intermediate for June delivery settled at $60.50 a barrel down 0.4 percent.

OTHER MARKETS:

Asian stocks were mixed Wednesday. Japan’s Nikkei Stock Average rose 0.7 percent while Hong Kong’s Hang Seng Index lost 0.6 percent. The Shanghai Composite fell 0.6 percent.



Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.